Report Detail
Global Drug Eluting Stents (DES) Market Insights and Forecast to 2026
- RnM4153036 |
- 24 August, 2020 |
- Global |
- 146 Pages |
- QYResearch |
- Medical Devices & Consumables
Drug Eluting Stents (DES) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Drug Eluting Stents (DES) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Drug Eluting Stents (DES) market is segmented into
Cobalt-chromium alloy Stents
Magnesium alloy Stents
Tyrosine polycarbonate Stents
Nitinol Stents
Platinum chromium alloy Stents
Stainless steel Stents
Other Materials
Segment by Application, the Drug Eluting Stents (DES) market is segmented into
Coronary Heart Disease
Clinical
Regional and Country-level Analysis
The Drug Eluting Stents (DES) market is analysed and market size information is provided by regions (countries).
The key regions covered in the Drug Eluting Stents (DES) market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Drug Eluting Stents (DES) Market Share Analysis
Drug Eluting Stents (DES) market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Drug Eluting Stents (DES) by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Drug Eluting Stents (DES) business, the date to enter into the Drug Eluting Stents (DES) market, Drug Eluting Stents (DES) product introduction, recent developments, etc.
The major vendors covered:
Abbott Vascular
Advantec Vascular
B.Braun Melsengen AG
Biosensors
Biotronik
Blue Medical
Boston Scientific
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
Terumo Medical
1 Study Coverage
- 1.1 Drug Eluting Stents (DES) Product Introduction
- 1.2 Key Market Segments in This Study
- 1.3 Key Manufacturers Covered: Ranking of Global Top Drug Eluting Stents (DES) Manufacturers by Revenue in 2019
- 1.4 Market by Type
- 1.4.1 Global Drug Eluting Stents (DES) Market Size Growth Rate by Type
- 1.4.2 Cobalt-chromium alloy Stents
- 1.4.3 Magnesium alloy Stents
- 1.4.4 Tyrosine polycarbonate Stents
- 1.4.5 Nitinol Stents
- 1.4.6 Platinum chromium alloy Stents
- 1.4.7 Stainless steel Stents
- 1.4.8 Other Materials
- 1.5 Market by Application
- 1.5.1 Global Drug Eluting Stents (DES) Market Size Growth Rate by Application
- 1.5.2 Coronary Heart Disease
- 1.5.3 Clinical
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Drug Eluting Stents (DES) Market Size, Estimates and Forecasts
- 2.1.1 Global Drug Eluting Stents (DES) Revenue Estimates and Forecasts 2015-2026
- 2.1.2 Global Drug Eluting Stents (DES) Production Capacity Estimates and Forecasts 2015-2026
- 2.1.3 Global Drug Eluting Stents (DES) Production Estimates and Forecasts 2015-2026
- 2.2 Global Drug Eluting Stents (DES), Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.3 Analysis of Competitive Landscape
- 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 2.3.2 Global Drug Eluting Stents (DES) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 2.3.3 Global Drug Eluting Stents (DES) Manufacturers Geographical Distribution
- 2.4 Key Trends for Drug Eluting Stents (DES) Markets & Products
- 2.5 Primary Interviews with Key Drug Eluting Stents (DES) Players (Opinion Leaders)
3 Market Size by Manufacturers
- 3.1 Global Top Drug Eluting Stents (DES) Manufacturers by Production Capacity
- 3.1.1 Global Top Drug Eluting Stents (DES) Manufacturers by Production Capacity (2015-2020)
- 3.1.2 Global Top Drug Eluting Stents (DES) Manufacturers by Production (2015-2020)
- 3.1.3 Global Top Drug Eluting Stents (DES) Manufacturers Market Share by Production
- 3.2 Global Top Drug Eluting Stents (DES) Manufacturers by Revenue
- 3.2.1 Global Top Drug Eluting Stents (DES) Manufacturers by Revenue (2015-2020)
- 3.2.2 Global Top Drug Eluting Stents (DES) Manufacturers Market Share by Revenue (2015-2020)
- 3.2.3 Global Top 10 and Top 5 Companies by Drug Eluting Stents (DES) Revenue in 2019
- 3.3 Global Drug Eluting Stents (DES) Price by Manufacturers
- 3.4 Mergers & Acquisitions, Expansion Plans
4 Drug Eluting Stents (DES) Production by Regions
- 4.1 Global Drug Eluting Stents (DES) Historic Market Facts & Figures by Regions
- 4.1.1 Global Top Drug Eluting Stents (DES) Regions by Production (2015-2020)
- 4.1.2 Global Top Drug Eluting Stents (DES) Regions by Revenue (2015-2020)
- 4.2 North America
- 4.2.1 North America Drug Eluting Stents (DES) Production (2015-2020)
- 4.2.2 North America Drug Eluting Stents (DES) Revenue (2015-2020)
- 4.2.3 Key Players in North America
- 4.2.4 North America Drug Eluting Stents (DES) Import & Export (2015-2020)
- 4.3 Europe
- 4.3.1 Europe Drug Eluting Stents (DES) Production (2015-2020)
- 4.3.2 Europe Drug Eluting Stents (DES) Revenue (2015-2020)
- 4.3.3 Key Players in Europe
- 4.3.4 Europe Drug Eluting Stents (DES) Import & Export (2015-2020)
- 4.4 China
- 4.4.1 China Drug Eluting Stents (DES) Production (2015-2020)
- 4.4.2 China Drug Eluting Stents (DES) Revenue (2015-2020)
- 4.4.3 Key Players in China
- 4.4.4 China Drug Eluting Stents (DES) Import & Export (2015-2020)
- 4.5 Japan
- 4.5.1 Japan Drug Eluting Stents (DES) Production (2015-2020)
- 4.5.2 Japan Drug Eluting Stents (DES) Revenue (2015-2020)
- 4.5.3 Key Players in Japan
- 4.5.4 Japan Drug Eluting Stents (DES) Import & Export (2015-2020)
5 Drug Eluting Stents (DES) Consumption by Region
- 5.1 Global Top Drug Eluting Stents (DES) Regions by Consumption
- 5.1.1 Global Top Drug Eluting Stents (DES) Regions by Consumption (2015-2020)
- 5.1.2 Global Top Drug Eluting Stents (DES) Regions Market Share by Consumption (2015-2020)
- 5.2 North America
- 5.2.1 North America Drug Eluting Stents (DES) Consumption by Application
- 5.2.2 North America Drug Eluting Stents (DES) Consumption by Countries
- 5.2.3 U.S.
- 5.2.4 Canada
- 5.3 Europe
- 5.3.1 Europe Drug Eluting Stents (DES) Consumption by Application
- 5.3.2 Europe Drug Eluting Stents (DES) Consumption by Countries
- 5.3.3 Germany
- 5.3.4 France
- 5.3.5 U.K.
- 5.3.6 Italy
- 5.3.7 Russia
- 5.4 Asia Pacific
- 5.4.1 Asia Pacific Drug Eluting Stents (DES) Consumption by Application
- 5.4.2 Asia Pacific Drug Eluting Stents (DES) Consumption by Regions
- 5.4.3 China
- 5.4.4 Japan
- 5.4.5 South Korea
- 5.4.6 India
- 5.4.7 Australia
- 5.4.8 Taiwan
- 5.4.9 Indonesia
- 5.4.10 Thailand
- 5.4.11 Malaysia
- 5.4.12 Philippines
- 5.4.13 Vietnam
- 5.5 Central & South America
- 5.5.1 Central & South America Drug Eluting Stents (DES) Consumption by Application
- 5.5.2 Central & South America Drug Eluting Stents (DES) Consumption by Country
- 5.5.3 Mexico
- 5.5.3 Brazil
- 5.5.3 Argentina
- 5.6 Middle East and Africa
- 5.6.1 Middle East and Africa Drug Eluting Stents (DES) Consumption by Application
- 5.6.2 Middle East and Africa Drug Eluting Stents (DES) Consumption by Countries
- 5.6.3 Turkey
- 5.6.4 Saudi Arabia
- 5.6.5 U.A.E
6 Market Size by Type (2015-2026)
- 6.1 Global Drug Eluting Stents (DES) Market Size by Type (2015-2020)
- 6.1.1 Global Drug Eluting Stents (DES) Production by Type (2015-2020)
- 6.1.2 Global Drug Eluting Stents (DES) Revenue by Type (2015-2020)
- 6.1.3 Drug Eluting Stents (DES) Price by Type (2015-2020)
- 6.2 Global Drug Eluting Stents (DES) Market Forecast by Type (2021-2026)
- 6.2.1 Global Drug Eluting Stents (DES) Production Forecast by Type (2021-2026)
- 6.2.2 Global Drug Eluting Stents (DES) Revenue Forecast by Type (2021-2026)
- 6.2.3 Global Drug Eluting Stents (DES) Price Forecast by Type (2021-2026)
- 6.3 Global Drug Eluting Stents (DES) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 Market Size by Application (2015-2026)
- 7.2.1 Global Drug Eluting Stents (DES) Consumption Historic Breakdown by Application (2015-2020)
- 7.2.2 Global Drug Eluting Stents (DES) Consumption Forecast by Application (2021-2026)
8 Corporate Profiles
- 8.1 Abbott Vascular
- 8.1.1 Abbott Vascular Corporation Information
- 8.1.2 Abbott Vascular Overview
- 8.1.3 Abbott Vascular Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.1.4 Abbott Vascular Product Description
- 8.1.5 Abbott Vascular Related Developments
- 8.2 Advantec Vascular
- 8.2.1 Advantec Vascular Corporation Information
- 8.2.2 Advantec Vascular Overview
- 8.2.3 Advantec Vascular Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.2.4 Advantec Vascular Product Description
- 8.2.5 Advantec Vascular Related Developments
- 8.3 B.Braun Melsengen AG
- 8.3.1 B.Braun Melsengen AG Corporation Information
- 8.3.2 B.Braun Melsengen AG Overview
- 8.3.3 B.Braun Melsengen AG Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.3.4 B.Braun Melsengen AG Product Description
- 8.3.5 B.Braun Melsengen AG Related Developments
- 8.4 Biosensors
- 8.4.1 Biosensors Corporation Information
- 8.4.2 Biosensors Overview
- 8.4.3 Biosensors Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.4.4 Biosensors Product Description
- 8.4.5 Biosensors Related Developments
- 8.5 Biotronik
- 8.5.1 Biotronik Corporation Information
- 8.5.2 Biotronik Overview
- 8.5.3 Biotronik Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.5.4 Biotronik Product Description
- 8.5.5 Biotronik Related Developments
- 8.6 Blue Medical
- 8.6.1 Blue Medical Corporation Information
- 8.6.2 Blue Medical Overview
- 8.6.3 Blue Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.6.4 Blue Medical Product Description
- 8.6.5 Blue Medical Related Developments
- 8.7 Boston Scientific
- 8.7.1 Boston Scientific Corporation Information
- 8.7.2 Boston Scientific Overview
- 8.7.3 Boston Scientific Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.7.4 Boston Scientific Product Description
- 8.7.5 Boston Scientific Related Developments
- 8.8 DISA Vascular
- 8.8.1 DISA Vascular Corporation Information
- 8.8.2 DISA Vascular Overview
- 8.8.3 DISA Vascular Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.8.4 DISA Vascular Product Description
- 8.8.5 DISA Vascular Related Developments
- 8.9 Essen
- 8.9.1 Essen Corporation Information
- 8.9.2 Essen Overview
- 8.9.3 Essen Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.9.4 Essen Product Description
- 8.9.5 Essen Related Developments
- 8.10 Medtronic Vascular
- 8.10.1 Medtronic Vascular Corporation Information
- 8.10.2 Medtronic Vascular Overview
- 8.10.3 Medtronic Vascular Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.10.4 Medtronic Vascular Product Description
- 8.10.5 Medtronic Vascular Related Developments
- 8.11 MicroPort Medical
- 8.11.1 MicroPort Medical Corporation Information
- 8.11.2 MicroPort Medical Overview
- 8.11.3 MicroPort Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.11.4 MicroPort Medical Product Description
- 8.11.5 MicroPort Medical Related Developments
- 8.12 MIV Therapeutics
- 8.12.1 MIV Therapeutics Corporation Information
- 8.12.2 MIV Therapeutics Overview
- 8.12.3 MIV Therapeutics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.12.4 MIV Therapeutics Product Description
- 8.12.5 MIV Therapeutics Related Developments
- 8.13 Orbusneich
- 8.13.1 Orbusneich Corporation Information
- 8.13.2 Orbusneich Overview
- 8.13.3 Orbusneich Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.13.4 Orbusneich Product Description
- 8.13.5 Orbusneich Related Developments
- 8.14 Promed Medical
- 8.14.1 Promed Medical Corporation Information
- 8.14.2 Promed Medical Overview
- 8.14.3 Promed Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.14.4 Promed Medical Product Description
- 8.14.5 Promed Medical Related Developments
- 8.15 Relisys Medical
- 8.15.1 Relisys Medical Corporation Information
- 8.15.2 Relisys Medical Overview
- 8.15.3 Relisys Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.15.4 Relisys Medical Product Description
- 8.15.5 Relisys Medical Related Developments
- 8.16 Reva Medical
- 8.16.1 Reva Medical Corporation Information
- 8.16.2 Reva Medical Overview
- 8.16.3 Reva Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.16.4 Reva Medical Product Description
- 8.16.5 Reva Medical Related Developments
- 8.17 Sahajanand
- 8.17.1 Sahajanand Corporation Information
- 8.17.2 Sahajanand Overview
- 8.17.3 Sahajanand Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.17.4 Sahajanand Product Description
- 8.17.5 Sahajanand Related Developments
- 8.18 Sino Medical
- 8.18.1 Sino Medical Corporation Information
- 8.18.2 Sino Medical Overview
- 8.18.3 Sino Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.18.4 Sino Medical Product Description
- 8.18.5 Sino Medical Related Developments
- 8.19 Sorin
- 8.19.1 Sorin Corporation Information
- 8.19.2 Sorin Overview
- 8.19.3 Sorin Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.19.4 Sorin Product Description
- 8.19.5 Sorin Related Developments
- 8.20 Terumo Medical
- 8.20.1 Terumo Medical Corporation Information
- 8.20.2 Terumo Medical Overview
- 8.20.3 Terumo Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.20.4 Terumo Medical Product Description
- 8.20.5 Terumo Medical Related Developments
9 Drug Eluting Stents (DES) Production Forecast by Regions
- 9.1 Global Top Drug Eluting Stents (DES) Regions Forecast by Revenue (2021-2026)
- 9.2 Global Top Drug Eluting Stents (DES) Regions Forecast by Production (2021-2026)
- 9.3 Key Drug Eluting Stents (DES) Production Regions Forecast
- 9.3.1 North America
- 9.3.2 Europe
- 9.3.3 China
- 9.3.4 Japan
10 Drug Eluting Stents (DES) Consumption Forecast by Region
- 10.1 Global Drug Eluting Stents (DES) Consumption Forecast by Region (2021-2026)
- 10.2 North America Drug Eluting Stents (DES) Consumption Forecast by Region (2021-2026)
- 10.3 Europe Drug Eluting Stents (DES) Consumption Forecast by Region (2021-2026)
- 10.4 Asia Pacific Drug Eluting Stents (DES) Consumption Forecast by Region (2021-2026)
- 10.5 Latin America Drug Eluting Stents (DES) Consumption Forecast by Region (2021-2026)
- 10.6 Middle East and Africa Drug Eluting Stents (DES) Consumption Forecast by Region (2021-2026)
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Drug Eluting Stents (DES) Sales Channels
- 11.2.2 Drug Eluting Stents (DES) Distributors
- 11.3 Drug Eluting Stents (DES) Customers
12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
- 12.1 Drug Eluting Stents (DES) Industry
- 12.2 Market Trends
- 12.3 Market Opportunities and Drivers
- 12.4 Market Challenges
- 12.5 Drug Eluting Stents (DES) Market Risks/Restraints
- 12.6 Porter's Five Forces Analysis
13 Key Finding in The Global Drug Eluting Stents (DES) Study
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.2 Data Source
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Drug Eluting Stents (DES). Industry analysis & Market Report on Drug Eluting Stents (DES) is a syndicated market report, published as Global Drug Eluting Stents (DES) Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Drug Eluting Stents (DES) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
